Erasca (ERAS) News Today $2.72 +0.13 (+5.02%) (As of 11/1/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Erasca Insiders Added US$1.95m Of Stock To Their HoldingsOctober 31 at 2:07 PM | finance.yahoo.comErasca (NASDAQ:ERAS) Stock Price Up 3.8% - Here's WhyErasca (NASDAQ:ERAS) Trading 3.8% Higher - What's Next?October 29, 2024 | marketbeat.comThe Goldman Sachs Group Raises Erasca (NASDAQ:ERAS) Price Target to $3.50October 29, 2024 | americanbankingnews.comErasca (NASDAQ:ERAS) Trading Down 3.4% - What's Next?Erasca (NASDAQ:ERAS) Stock Price Down 3.4% - Should You Sell?October 28, 2024 | marketbeat.comErasca (NASDAQ:ERAS) PT Raised to $3.50The Goldman Sachs Group increased their price target on Erasca from $3.00 to $3.50 and gave the stock a "buy" rating in a report on Friday.October 25, 2024 | marketbeat.comErasca's (ERAS) Buy Rating Reiterated at HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $6.00 price target on shares of Erasca in a research report on Friday.October 25, 2024 | marketbeat.comErasca announces clinical progress for naporafenibOctober 25, 2024 | markets.businessinsider.comErasca Announces Strong Momentum for Naporafenib and RAS Targeting FranchiseOctober 24, 2024 | markets.businessinsider.comErasca: New Focus After Restructuring, But Need More DifferentiationSeptember 30, 2024 | seekingalpha.comMarshall Wace LLP Makes New Investment in Erasca, Inc. (NASDAQ:ERAS)Marshall Wace LLP bought a new stake in shares of Erasca, Inc. (NASDAQ:ERAS - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 3,672,375 shares of the company's stock, valued at approximately $8,September 30, 2024 | marketbeat.comFrazier Life Sciences Management L.P. Invests $38.27 Million in Erasca, Inc. (NASDAQ:ERAS)Frazier Life Sciences Management L.P. acquired a new position in shares of Erasca, Inc. (NASDAQ:ERAS - Free Report) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 16,216,216 shares of the company's stock, valued at approximately $38September 29, 2024 | marketbeat.comAffinity Asset Advisors LLC Invests $5.90 Million in Erasca, Inc. (NASDAQ:ERAS)Affinity Asset Advisors LLC purchased a new position in shares of Erasca, Inc. (NASDAQ:ERAS - Free Report) during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 2,499,431 shares of the company's stock, valued at approximatelySeptember 25, 2024 | marketbeat.comLogos Global Management LP Acquires New Shares in Erasca, Inc. (NASDAQ:ERAS)Logos Global Management LP acquired a new stake in shares of Erasca, Inc. (NASDAQ:ERAS - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 5,900,000 shares of the company's stock, valued at approSeptember 24, 2024 | marketbeat.comErasca, Inc. (NASDAQ:ERAS) is favoured by institutional owners who hold 61% of the companySeptember 24, 2024 | finance.yahoo.comSofinnova Investments Inc. Makes New $4.01 Million Investment in Erasca, Inc. (NASDAQ:ERAS)Sofinnova Investments Inc. bought a new stake in shares of Erasca, Inc. (NASDAQ:ERAS - Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 1,699,528 shares of the company's stock, valued at approximately $4,011,000September 17, 2024 | marketbeat.comErasca (NASDAQ:ERAS) Shares Down 2% Erasca (NASDAQ:ERAS) Shares Down 2%September 13, 2024 | marketbeat.comErasca (NASDAQ:ERAS) Shares Up 5%Erasca (NASDAQ:ERAS) Trading 5% HigherSeptember 5, 2024 | marketbeat.comErasca to Present at Upcoming Investor Conferences in SeptemberAugust 29, 2024 | finance.yahoo.comVanguard Group Inc. Acquires 545,765 Shares of Erasca, Inc. (NASDAQ:ERAS)Vanguard Group Inc. increased its holdings in shares of Erasca, Inc. (NASDAQ:ERAS - Free Report) by 14.4% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,338,108 shares of the company's stock afterAugust 16, 2024 | marketbeat.comMorgan Stanley Keeps Their Buy Rating on Erasca (ERAS)August 15, 2024 | markets.businessinsider.comQ3 2024 EPS Estimates for Erasca, Inc. (NASDAQ:ERAS) Cut by Capital One FinancialErasca, Inc. (NASDAQ:ERAS - Free Report) - Capital One Financial cut their Q3 2024 earnings estimates for shares of Erasca in a research report issued on Monday, August 12th. Capital One Financial analyst N. Quibria now expects that the company will post earnings per share of ($0.21) for the quarAugust 15, 2024 | marketbeat.comErasca stock target raised on SEACRAFT-2 study optimismAugust 15, 2024 | uk.investing.comWe're Hopeful That Erasca (NASDAQ:ERAS) Will Use Its Cash WiselyAugust 15, 2024 | finance.yahoo.comErasca Inc. Poised for Growth: Buy Rating Maintained Amidst Promising Trial Updates and Solid FinancialsAugust 13, 2024 | markets.businessinsider.comErasca (NASDAQ:ERAS) Releases Quarterly Earnings Results, Misses Estimates By $0.12 EPSErasca (NASDAQ:ERAS - Get Free Report) announced its earnings results on Monday. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by ($0.12).August 13, 2024 | marketbeat.comErasca’s Innovative Melanoma Treatments Prompt Buy RatingAugust 13, 2024 | markets.businessinsider.comErasca (NASDAQ:ERAS) Price Target Increased to $6.00 by Analysts at HC WainwrightHC Wainwright increased their price target on shares of Erasca from $5.00 to $6.00 and gave the stock a "buy" rating in a research note on Tuesday.August 13, 2024 | marketbeat.comErasca Reports Second Quarter 2024 Business Updates and Financial ResultsAugust 12, 2024 | globenewswire.comErasca, Inc. (NASDAQ:ERAS) Short Interest Up 9.0% in JulyErasca, Inc. (NASDAQ:ERAS - Get Free Report) was the recipient of a large growth in short interest during the month of July. As of July 15th, there was short interest totalling 21,810,000 shares, a growth of 9.0% from the June 30th total of 20,010,000 shares. Based on an average daily volume of 2,300,000 shares, the short-interest ratio is currently 9.5 days. Currently, 13.1% of the company's shares are short sold.July 30, 2024 | marketbeat.comErasca, Inc. (NASDAQ:ERAS) Shares Purchased by Acadian Asset Management LLCAcadian Asset Management LLC boosted its holdings in Erasca, Inc. (NASDAQ:ERAS - Free Report) by 286.5% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 346,953 shares of the company's stock after acquiring an aJuly 27, 2024 | marketbeat.comErasca (NASDAQ:ERAS) Sets New 12-Month High at $3.38Erasca (NASDAQ:ERAS) Reaches New 1-Year High at $3.38July 26, 2024 | marketbeat.comErasca (NASDAQ:ERAS) Reaches New 1-Year High at $3.33Erasca (NASDAQ:ERAS) Sets New 12-Month High at $3.33July 18, 2024 | marketbeat.comErasca (NASDAQ:ERAS) Trading 4.9% Higher Erasca (NASDAQ:ERAS) Stock Price Up 4.9%July 17, 2024 | marketbeat.comCVI Holdings LLC Buys Shares of 1,456,311 Erasca, Inc. (NASDAQ:ERAS)CVI Holdings LLC bought a new stake in shares of Erasca, Inc. (NASDAQ:ERAS - Free Report) in the first quarter, according to its most recent Form 13F filing with the SEC. The fund bought 1,456,311 shares of the company's stock, valued at approximately $3,000,000. Erasca accounts for 2.9% of CVI HoJuly 14, 2024 | marketbeat.comErasca (NASDAQ:ERAS) Reaches New 12-Month High at $3.10Erasca (NASDAQ:ERAS) Sets New 52-Week High at $3.10July 12, 2024 | marketbeat.comErasca (NASDAQ:ERAS) Trading Up 8.3%Erasca (NASDAQ:ERAS) Trading 8.3% HigherJuly 9, 2024 | marketbeat.comErasca to Present at Upcoming Investor Conferences in JuneMay 29, 2024 | globenewswire.comErasca (NASDAQ:ERAS) PT Lowered to $4.00 at The Goldman Sachs GroupThe Goldman Sachs Group reduced their target price on Erasca from $7.00 to $4.00 and set a "buy" rating on the stock in a report on Tuesday.May 28, 2024 | marketbeat.comIndependent Director of Erasca Picks Up 14% More StockMay 23, 2024 | finance.yahoo.comErasca, Inc. (NASDAQ:ERAS) Director Alexander W. Casdin Purchases 80,000 SharesMay 23, 2024 | insidertrades.comErasca, Inc. (NASDAQ:ERAS) to Post Q2 2024 Earnings of ($0.17) Per Share, Capital One Financial ForecastsErasca, Inc. (NASDAQ:ERAS - Free Report) - Investment analysts at Capital One Financial boosted their Q2 2024 EPS estimates for Erasca in a report issued on Monday, May 20th. Capital One Financial analyst N. Quibria now anticipates that the company will earn ($0.17) per share for the quarter, upMay 23, 2024 | marketbeat.comInsider Buying: Erasca, Inc. (NASDAQ:ERAS) Director Acquires 80,000 Shares of StockErasca, Inc. (NASDAQ:ERAS - Get Free Report) Director Alexander W. Casdin purchased 80,000 shares of the stock in a transaction that occurred on Tuesday, May 21st. The stock was purchased at an average cost of $2.27 per share, with a total value of $181,600.00. Following the purchase, the director now owns 573,974 shares in the company, valued at approximately $1,302,920.98. The purchase was disclosed in a filing with the SEC, which can be accessed through this link.May 22, 2024 | marketbeat.comQ2 2024 EPS Estimates for Erasca, Inc. (NASDAQ:ERAS) Increased by AnalystErasca, Inc. (NASDAQ:ERAS - Free Report) - Equities researchers at HC Wainwright upped their Q2 2024 earnings per share (EPS) estimates for Erasca in a research note issued to investors on Monday, May 20th. HC Wainwright analyst A. Maldonado now anticipates that the company will post earnings ofMay 22, 2024 | marketbeat.comErasca Announces Closing of Underwritten Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional SharesMay 21, 2024 | finance.yahoo.comErasca Announces Closing of Underwritten Offering of Common Stock and Full Exercise of the Underwriters' Option to Purchase Additional SharesMay 21, 2024 | globenewswire.comErasca Inc. Earns Buy Rating: Strategic Acquisitions and Promising Pipeline PositioningMay 20, 2024 | markets.businessinsider.comOptimistic Outlook for Erasca: Strategic Growth and Financial PrudenceMay 20, 2024 | markets.businessinsider.comErasca stock climbs 10% amid pipeline restructuring, equity offeringMay 17, 2024 | msn.comErasca Announces Strategic In-Licensing of RAS-Targeting FranchiseMay 16, 2024 | globenewswire.comErasca Announces Pricing of Underwritten Offering of Common StockMay 16, 2024 | globenewswire.com Get Erasca News Delivered to You Automatically Sign up to receive the latest news and ratings for ERAS and its competitors with MarketBeat's FREE daily newsletter. Email Address 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here ERAS Media Mentions By Week ERAS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ERAS News Sentiment▼0.000.43▲Average Medical News Sentiment ERAS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ERAS Articles This Week▼41▲ERAS Articles Average Week Get Erasca News Delivered to You Automatically Sign up to receive the latest news and ratings for ERAS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Relay Therapeutics News Nuvation Bio News Verve Therapeutics News Bicycle Therapeutics News Lyell Immunopharma News Black Diamond Therapeutics News Zai Lab News Rhythm Pharmaceuticals News MoonLake Immunotherapeutics News Dyne Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ERAS) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Erasca, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Erasca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
